National Vaccine
Information Center

Your Health. Your Family. Your Choice.

MedAlerts.org
Search Results

From the 1/7/2022 release of VAERS data:

Found 39,863 cases where Vaccine is COVID19 and Symptom is Anaphylactic reaction or Anaphylactic shock or Anaphylactoid reaction or Anaphylactoid shock or Swollen tongue or Tongue paralysis or Tongue pruritus or Urticaria or Urticaria aquagenic or Urticaria cholinergic or Urticaria chronic or Urticaria contact or Urticaria generalised or Urticarial vasculitis or Urticaria papular or Urticaria pigmentosa or Urticaria pressure or Urticaria thermal or Urticaria vesiculosa

Government Disclaimer on use of this data



Case Details

This is page 19 out of 3,987

Result pages: prev   10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28   next


VAERS ID: 907164 (history)  
Form: Version 2.0  
Age: 36.0  
Sex: Female  
Location: California  
Vaccinated:2020-12-21
Onset:2020-12-22
   Days after vaccination:1
Submitted: 0000-00-00
Entered: 2020-12-22
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH ELO140 / 1 RA / IM

Administered by: Private       Purchased by: ?
Symptoms: Urticaria
SMQs:, Anaphylactic reaction (broad), Angioedema (narrow), Hypersensitivity (narrow), Drug reaction with eosinophilia and systemic symptoms syndrome (broad)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications: multivitamin, melatonin
Current Illness: none
Preexisting Conditions: none
Allergies: sulfa
Diagnostic Lab Data:
CDC Split Type:

Write-up: HIVES starting 32 Horus vaccines, unclear if related, took Benadryl,


VAERS ID: 907166 (history)  
Form: Version 2.0  
Age: 36.0  
Sex: Female  
Location: Virginia  
Vaccinated:2020-12-19
Onset:2020-12-20
   Days after vaccination:1
Submitted: 0000-00-00
Entered: 2020-12-22
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH EH9899 / 1 RA / IM

Administered by: Private       Purchased by: ?
Symptoms: Anxiety, Burning sensation, Dry mouth, Dyspnoea, Electrocardiogram, Hot flush, Injection site pain, Mouth ulceration, Palpitations, Tremor, Urticaria
SMQs:, Severe cutaneous adverse reactions (broad), Anaphylactic reaction (narrow), Angioedema (narrow), Peripheral neuropathy (broad), Neuroleptic malignant syndrome (broad), Systemic lupus erythematosus (broad), Anticholinergic syndrome (broad), Arrhythmia related investigations, signs and symptoms (broad), Parkinson-like events (broad), Oropharyngeal conditions (excl neoplasms, infections and allergies) (narrow), Acute central respiratory depression (broad), Pulmonary hypertension (broad), Noninfectious encephalopathy/delirium (broad), Extravasation events (injections, infusions and implants) (broad), Cardiomyopathy (broad), Hypersensitivity (narrow), Drug reaction with eosinophilia and systemic symptoms syndrome (broad), Hypoglycaemia (broad), Dehydration (broad)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? Yes
Hospitalized? No
Previous Vaccinations:
Other Medications: vitamin c. zinc, regularly tylenol as needed and for the reaction ; ibuprofen, benedryl, pepcid
Current Illness: ear infection week prior. month ago "chest pain".
Preexisting Conditions: nothing.
Allergies: pennicillin, percocet, dilaudid, ivy, mums (plant),
Diagnostic Lab Data: EKG. 0xygen saturation. on admission at 12/22/20
CDC Split Type:

Write-up: hives on torso, legs and arms and groin. Ulcers in mouth. burning at site of injection. dry mouth and burning sensation in mouth. shortness of breath. palpitations. anxiety. tremors. hot flashes.


VAERS ID: 907173 (history)  
Form: Version 2.0  
Age: 52.0  
Sex: Female  
Location: North Carolina  
Vaccinated:2020-12-22
Onset:2020-12-22
   Days after vaccination:0
Submitted: 0000-00-00
Entered: 2020-12-23
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH - / UNK LA / IM

Administered by: Private       Purchased by: ?
Symptoms: Anaphylactic reaction, Respiratory tract oedema, Stridor, Urticaria, Wheezing
SMQs:, Anaphylactic reaction (narrow), Angioedema (narrow), Asthma/bronchospasm (broad), Anaphylactic/anaphylactoid shock conditions (narrow), Eosinophilic pneumonia (broad), Hypersensitivity (narrow), Drug reaction with eosinophilia and systemic symptoms syndrome (broad)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? Yes
Office Visit? No
ER Visit? No
ER or Doctor Visit? Yes
Hospitalized? No
Previous Vaccinations:
Other Medications: Advair, Tylenol, Flexeril, Zyrtec, Norco, Singulair, Janumet, Turmeric, vitamin A
Current Illness:
Preexisting Conditions: Obesity, asthma
Allergies: Metoprolol, Biaxin, Lopressors, Robaxin,
Diagnostic Lab Data:
CDC Split Type:

Write-up: Anaphylaxis reaction with hives, stridor/airway edema, wheezing


VAERS ID: 907177 (history)  
Form: Version 2.0  
Age:   
Sex: Male  
Location: Texas  
Vaccinated:0000-00-00
Onset:0000-00-00
Submitted: 0000-00-00
Entered: 2020-12-23
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH - / UNK - / -

Administered by: Unknown       Purchased by: ?
Symptoms: Dyspnoea, Rash, Swollen tongue
SMQs:, Anaphylactic reaction (narrow), Angioedema (narrow), Oropharyngeal allergic conditions (narrow), Oropharyngeal conditions (excl neoplasms, infections and allergies) (narrow), Acute central respiratory depression (broad), Pulmonary hypertension (broad), Cardiomyopathy (broad), Hypersensitivity (narrow), Drug reaction with eosinophilia and systemic symptoms syndrome (broad)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? Yes
Hospitalized? No
Previous Vaccinations:
Other Medications:
Current Illness:
Preexisting Conditions:
Allergies:
Diagnostic Lab Data:
CDC Split Type: USPFIZER INC2020500219

Write-up: developed swelling of tongue; dyspnea; skin rash; This is a spontaneous report from a non-contactable consumer. A 35-year-old male patient received BNT162B2, via an unspecified route of administration on an unspecified date in 2020 at a single dose for COVID-19 immunization. The patient''s medical history and concomitant medications were not reported. This is a call from CDC this morning regarding a new case, the patient was administered vaccine and developed swelling of tongue, dyspnea, skin rash on an unspecified date in 2020, then treated with dexamethasone, diphenhydramine hydrochloride (BENADRYL), via intramuscular (IM) epinephrine in emergency room (ER). The outcome of events was unknown. She will alert him each time there is a report of severe hypersensitivity for his awareness. Further, the CDC is in the process of appointing a contact who will be able to meet with us regularly on this topic. Their conversation was amicable and demonstrated a willingness to work closely with us as we navigate the issue of hypersensitivity. No follow-up attempts are possible; Information about lot/batch number cannot be obtained.; Sender''s Comments: The reported information is limited. Based on the temporal relationship and the description of the events, swelling of tongue, dyspnea, skin rash, there is a reasonable possibility that the events are related to BNT162 vaccine. The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to regulatory authorities, Ethics Committees, and Investigators, as appropriate.


VAERS ID: 907180 (history)  
Form: Version 2.0  
Age:   
Sex: Female  
Location: Unknown  
Vaccinated:2020-12-17
Onset:0000-00-00
Submitted: 0000-00-00
Entered: 2020-12-23
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH - / UNK - / -

Administered by: Unknown       Purchased by: ?
Symptoms: Haemodynamic test normal, Throat irritation, Tongue pruritus
SMQs:, Oropharyngeal conditions (excl neoplasms, infections and allergies) (narrow)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? Yes
Hospitalized? No
Previous Vaccinations:
Other Medications:
Current Illness:
Preexisting Conditions:
Allergies:
Diagnostic Lab Data: Test Name: hemodynamics; Result Unstructured Data: Test Result:normal
CDC Split Type: USPFIZER INC2020500236

Write-up: itchy throat; itchy throat/back of the tongue reaction; This is a spontaneous report from a contactable physician. This physician reported similar events for two patients. This is the first report. A female patient of an unspecified age (reported as 50, unit unknown) received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number and expiry date were not provided), via an unspecified route of administration on 17Dec2020 22:00 at a single dose for COVID-19 immunisation. The patient''s medical history and concomitant medications were not reported. The patient experienced itchy throat/back of the tongue reaction. No rash, then they gave her epi 10, ED (emergency department) doctor assessed for 2 hours. No evidence of tongue swelling, hemodynamics was normal. Outcome of the events was unknown. Information on the lot/batch number has been requested.; Sender''s Comments: Based on the close temporal relationship and the description of the events, itchy throat/ tongue reaction there is a reasonable possibility that the events are related to BNT162 vaccine. The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to regulatory authorities, Ethics Committees, and Investigators, as appropriate.,Linked Report(s) : US-PFIZER INC-2020500303 Same reporter, product, and event, different patient


VAERS ID: 907183 (history)  
Form: Version 2.0  
Age: 32.0  
Sex: Female  
Location: California  
Vaccinated:2020-12-21
Onset:2020-12-21
   Days after vaccination:0
Submitted: 0000-00-00
Entered: 2020-12-23
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH EH9899 / 1 RA / IM

Administered by: Private       Purchased by: ?
Symptoms: Burning sensation, Immediate post-injection reaction, Injection site erythema, Injection site pain, Injection site swelling, Pain, Urticaria
SMQs:, Anaphylactic reaction (broad), Angioedema (narrow), Peripheral neuropathy (broad), Extravasation events (injections, infusions and implants) (broad), Haemodynamic oedema, effusions and fluid overload (narrow), Hypersensitivity (narrow), Drug reaction with eosinophilia and systemic symptoms syndrome (broad)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications: Tylenol, melatonin, ibuprofen
Current Illness: None
Preexisting Conditions: Asthma
Allergies: Cefazolin
Diagnostic Lab Data: N/A
CDC Split Type:

Write-up: Pfizer-BoiTech COVID-19 Vaccine Immediate burning at injection site following dose. (Similar to the sensation of receiving contrast for a CT scan) which I found odd. Injection site pain continued over night, swelling and site redness to follow and A 1.5 inch welt appeared approx 24hrs after receiving vaccine. Pain is localized to the injection site only . Treatment includes rest and Tylenol with little effect. Continuing to monitor for any further developments or additional side effects.


VAERS ID: 907187 (history)  
Form: Version 2.0  
Age: 48.0  
Sex: Female  
Location: South Carolina  
Vaccinated:2020-12-17
Onset:2020-12-17
   Days after vaccination:0
Submitted: 0000-00-00
Entered: 2020-12-23
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH - / UNK - / -

Administered by: Private       Purchased by: ?
Symptoms: Oropharyngeal discomfort, Paraesthesia oral, Pharyngeal swelling, Physical examination normal, Swelling, Swollen tongue
SMQs:, Anaphylactic reaction (narrow), Angioedema (narrow), Oropharyngeal allergic conditions (narrow), Oropharyngeal conditions (excl neoplasms, infections and allergies) (narrow), Guillain-Barre syndrome (broad), Haemodynamic oedema, effusions and fluid overload (narrow), Hypersensitivity (narrow), Drug reaction with eosinophilia and systemic symptoms syndrome (broad)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? Yes
Hospitalized? No
Previous Vaccinations:
Other Medications:
Current Illness: Drug allergy; Food allergy
Preexisting Conditions:
Allergies:
Diagnostic Lab Data: Test Name: Physical exam; Result Unstructured Data: Test Result:No abnormal; Comments: No abnormal physical exam findings
CDC Split Type: USPFIZER INC2020500532

Write-up: Possible allergic reaction - paresthesias of L tongue and throat; Possible allergic reaction - paresthesias of L tongue and throat; Possible allergic reaction - paresthesias of L tongue and throat; Sensation of tongue and throat swelling; Sensation of tongue and throat swelling; This is a spontaneous report from a contactable Health Care Professional. A 48 years old non-pregnant female patient received BNT162B2 (Pfizer-Biontech covid-19 vaccine) on 17Dec2020 at 15:15, at single dose, for COVID-19 immunisation. The vaccine was administered at hospital. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Relevant medical history included food and drug allergy. The patient received concomitant medications (unspecified, received within 2 weeks of vaccination). Prior to vaccination, the patient was not diagnosed with COVID-19 and since the vaccination, the patient has not been tested for COVID-19. On 17Dec2020 at 15:15, the patient experienced possible allergic reaction - paresthesias of L tongue and throat, with sensation of tongue and throat swelling. No anaphylaxis. No abnormal physical exam findings. Emergency Room Visit required and the patient received the following treatment: diphenhydramine hydrochloride (BENADRYL), prednisone, and loratadine (CLARITIN). Clinical outcome of the adverse events was unknown at time of this report. The case was assessed as non-serious. Information on the lot/batch number has been requested.


VAERS ID: 907214 (history)  
Form: Version 2.0  
Age:   
Sex: Female  
Location: Louisiana  
Vaccinated:2020-12-18
Onset:2020-12-18
   Days after vaccination:0
Submitted: 0000-00-00
Entered: 2020-12-23
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH PAA156051-EK573 / UNK - / -

Administered by: Private       Purchased by: ?
Symptoms: Urticaria
SMQs:, Anaphylactic reaction (broad), Angioedema (narrow), Hypersensitivity (narrow), Drug reaction with eosinophilia and systemic symptoms syndrome (broad)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications:
Current Illness:
Preexisting Conditions: Comments: List of non-encoded Patient Relevant History: Patient Other Relevant History 1: None
Allergies:
Diagnostic Lab Data:
CDC Split Type: USPFIZER INC2020504469

Write-up: Hives in her face; This is a spontaneous report from a contactable consumer (patient). A female patient of an unspecified age received BNT162B2 (Pfizer-Biontech covid-19 vaccine, Lot. PAA156051-EK5730) on 18Dec2020 at 10:15, at single dose, for COVID-19 immunisation. The vaccine was administered at hospital. Relevant medical history was none. Concomitant medications were unknown. On 18Dec2020, the patient experienced hives in her face. The patient was treated with diphenhydramine hydrochloride (BENADRYL). Clinical outcome of the adverse event was unknown at time of this report.


VAERS ID: 907254 (history)  
Form: Version 2.0  
Age: 32.0  
Sex: Female  
Location: Connecticut  
Vaccinated:2020-12-23
Onset:2020-12-23
   Days after vaccination:0
Submitted: 0000-00-00
Entered: 2020-12-23
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (MODERNA)) / MODERNA 011J20A / 1 RA / IM

Administered by: Private       Purchased by: ?
Symptoms: Erythema, Injection site pruritus, Rash, Urticaria
SMQs:, Anaphylactic reaction (broad), Angioedema (narrow), Hypersensitivity (narrow), Drug reaction with eosinophilia and systemic symptoms syndrome (broad)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? Yes
Office Visit? No
ER Visit? No
ER or Doctor Visit? Yes
Hospitalized? No
Previous Vaccinations: Flu vaccine Flucelvax
Other Medications: Benadryl 50 mg po prior to vaccine
Current Illness: none
Preexisting Conditions: Thyroid disease Migraine Allergic rhinitis GERD (gastroesophageal reflux disease) Visual impairment
Allergies: Amoxicillin Penicillin Cefzil food and nut
Diagnostic Lab Data: Solumedrol 125 IM Pepcid 20 mg po
CDC Split Type:

Write-up: Approx 10 min after receiving vaccine- patient developed rash and hives on neck and chest with complaints of itchiness on R arm at vaccine site. Also developed redness to right ear. no respiratory difficulties noted. Patient transported to ED for further evaluation and treatment


VAERS ID: 907256 (history)  
Form: Version 2.0  
Age: 35.0  
Sex: Female  
Location: Alaska  
Vaccinated:2020-12-22
Onset:2020-12-22
   Days after vaccination:0
Submitted: 0000-00-00
Entered: 2020-12-23
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH EH9899 / 1 LA / IM

Administered by: Private       Purchased by: ?
Symptoms: Anaphylactic reaction, Anxiety, Dysphagia, Heart rate increased, Injection site pain, Oropharyngeal discomfort, Pain, Pain in jaw, Pain of skin, Palpitations, Peripheral coldness, Pharyngeal swelling, Swelling face
SMQs:, Anaphylactic reaction (narrow), Angioedema (narrow), Neuroleptic malignant syndrome (broad), Anticholinergic syndrome (broad), Arrhythmia related investigations, signs and symptoms (broad), Anaphylactic/anaphylactoid shock conditions (narrow), Oropharyngeal conditions (excl neoplasms, infections and allergies) (narrow), Guillain-Barre syndrome (broad), Noninfectious encephalitis (broad), Noninfectious encephalopathy/delirium (broad), Noninfectious meningitis (broad), Extravasation events (injections, infusions and implants) (broad), Gastrointestinal nonspecific symptoms and therapeutic procedures (broad), Cardiomyopathy (broad), Osteonecrosis (broad), Hypersensitivity (narrow), Drug reaction with eosinophilia and systemic symptoms syndrome (broad), Hypoglycaemia (broad), Dehydration (broad)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? Yes
Hospitalized? No
Previous Vaccinations:
Other Medications:
Current Illness:
Preexisting Conditions:
Allergies: Septra
Diagnostic Lab Data:
CDC Split Type:

Write-up: *Describe the adverse event(s), treatment, and outcome(s), if any: (symptoms, signs, time course, etc.) S: 35 yo F who received Pfizer vaccine at 16:47 w/acute onset of left sided facial swelling and difficulty swallowing. Within five minutes of being administered vaccination, pt reported pain at the injection site radiating up to her jaw followed by left sided facial swelling. She started reported palpitations and subsequently reported a ball in her throat O: Pulse was in the 60''s, BP of 128/72, pulse of 88-97 satting at 99% on RA. General: young female, anxious. HEENT: NC, AT, mild left sided cheek swelling, OP clear, MMM. Neck: Supple, left sided tender cervical LN. Lungs: CTAB. CV: tachycardic rate, regular rhythm. Extremities: Hands are clenched and cold. Neuro: Alert & oriented. A/P: Anaphylaxis -Given left facial swelling, 25 mg Benadryl PO administered. pt tolerated well. -17:22-Throat swelling reported. EPI #1 administered right thigh. -17:32-EPI #2 administered. Throat felt better at 17:35. 17:36-FD EMS arrived. BP 194/126. -17:38-EPI #3 administered right thigh. HR 135, BP 154/105. -17:43-EPI #4 administered left thigh. -17:46 pt transported to ER via EMS.


Result pages: prev   10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28   next

New Search

Link To This Search Result:

https://www.medalerts.org/vaersdb/findfield.php?EVENTS=ON&PAGENO=19&SYMPTOMS[]=Anaphylactic_reaction_%2810002198%29&SYMPTOMS[]=Anaphylactic_shock_%2810002199%29&SYMPTOMS[]=Anaphylactoid_reaction_%2810002216%29&SYMPTOMS[]=Anaphylactoid_shock_%2810063119%29&SYMPTOMS[]=Swollen_tongue_%2810042727%29&SYMPTOMS[]=Tongue_paralysis_%2810043972%29&SYMPTOMS[]=Tongue_pruritus_%2810070072%29&SYMPTOMS[]=Urticaria_%2810046735%29&SYMPTOMS[]=Urticaria_aquagenic_%2810046739%29&SYMPTOMS[]=Urticaria_cholinergic_%2810046740%29&SYMPTOMS[]=Urticaria_chronic_%2810052568%29&SYMPTOMS[]=Urticaria_contact_%2810046742%29&SYMPTOMS[]=Urticaria_generalised_%2810052569%29&SYMPTOMS[]=Urticarial_vasculitis_%2810048820%29&SYMPTOMS[]=Urticaria_papular_%2810046750%29&SYMPTOMS[]=Urticaria_pigmentosa_%2810046752%29&SYMPTOMS[]=Urticaria_pressure_%2810052572%29&SYMPTOMS[]=Urticaria_thermal_%2810061399%29&SYMPTOMS[]=Urticaria_vesiculosa_%2810046755%29&VAX=COVID19


Copyright © 2022 National Vaccine Information Center. All rights reserved.
21525 Ridgetop Circle, Suite 100, Sterling, VA 20166